BAKER BROS. ADVISORS LP

Holdings History for Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA)

Symbol: TARA on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.03%	+0.01%	$5,178,703	971,614	+434,782	+81%	$5.33	Q4 2025
30 Sep 2025	0.02%	0%	$2,335,219	536,832	0		$4.35	Q3 2025
30 Jun 2025	0.02%	0%	$1,626,601	536,832	0		$3.03	Q2 2025
31 Mar 2025	0.03%	0%	$2,286,904	536,832	0		$4.26	Q1 2025
31 Dec 2024	0.03%	0%	$2,834,473	536,832	0		$5.28	Q4 2024
30 Sep 2024	0.01%	0%	$982,403	536,832	0		$1.83	Q3 2024
30 Jun 2024	0.01%	+0.01%	$1,116,611	536,832	+337,161	+169%	$2.08	Q2 2024
31 Mar 2024	0.01%	0%	$800,681	199,671	0		$4.01	Q1 2024
31 Dec 2023	0%	0%	$374,403	199,671	0		$1.88	Q4 2023
30 Sep 2023	0%	0%	$333,451	199,671	0		$1.67	Q3 2023
30 Jun 2023	0%	0%	$477,214	199,671	0		$2.39	Q2 2023
31 Mar 2023	0%	0%	$624,970	199,671	0		$3.13	Q1 2023
31 Dec 2022	0%	0%	$535,118	199,671	0		$2.68	Q4 2022
30 Sep 2022	0%	0%	$591,000	199,671	0		$2.96	Q3 2022
30 Jun 2022	0%	0%	$585,000	199,671	0		$2.93	Q2 2022
31 Mar 2022	0.01%	0%	$1,020,000	199,671	0		$5.11	Q1 2022
31 Dec 2021	0.01%	0%	$1,348,000	199,671	0		$6.75	Q4 2021
30 Sep 2021	0.01%	0%	$1,382,000	199,671	0		$6.92	Q3 2021
30 Jun 2021	0.01%	0%	$1,945,000	199,671	0		$9.74	Q2 2021
31 Mar 2021	0.01%	0%	$3,143,000	199,671	0		$15.74	Q1 2021
31 Dec 2020	0.02%	0%	$4,834,000	199,671	0		$24.21	Q4 2020
30 Sep 2020	0.01%	0%	$3,360,000	199,671	0		$16.83	Q3 2020
30 Jun 2020	0.03%	+0.03%	$5,854,000	199,671	+199,671	NEW	$29.32	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.